Monitoring ibuprofen enantiomers released from polymeric systems

Eur J Pharm Sci. 2002 Jul;16(1-2):75-82. doi: 10.1016/s0928-0987(02)00059-3.

Abstract

Two methacrylic derivatives of ibuprofen (N-[4-[2-(4-isobutylphenyl)propionyloxy]phenyl] methacrylamide (MAI) and 2-[(4-isobutylphenyl)propionyloxy]ethyl methacrylate (MEI)) were used together with 2-hydroxyethyl methacrylate (HEMA) to synthesize four polymeric materials: two hydrophobic homopolymers, PMAI and PMEI, and two hydrophilic copolymers containing 70% (w/w) HEMA, MAI-HEMA 30 and MEI-HEMA 30. The enantiomeric determination of R- and S-IBU released from these four systems has been carried out by capillary electrophoresis. Release of R- and S-IBU was monitored during in vitro assays done at 37 degrees C at pH 7.4 and 10 in buffered solutions and rat plasma. There is a hydrolytical activation in plasma and at pH 10 compared to pH 7.4; moreover, the release rate from the copolymers is much higher than from the homopolymers as a consequence of the greater hydrophilic character. A slight excess of the S-enantiomer of IBU is observed in all the experiments, being more relevant at higher release rates, i.e. copolymers at pH 10.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Delayed-Action Preparations
  • Drug Carriers
  • Electrophoresis, Capillary
  • Hydrogen-Ion Concentration
  • Ibuprofen / chemistry*
  • In Vitro Techniques
  • Male
  • Methacrylates / chemistry*
  • Polymers / chemistry*
  • Rats
  • Rats, Wistar
  • Stereoisomerism
  • Time Factors

Substances

  • 2-((4-isobutylphenyl)propionyloxy)ethyl methacrylate
  • Delayed-Action Preparations
  • Drug Carriers
  • Methacrylates
  • N-(4-(2-(4-isobutylphenyl)propionyloxy)phenyl)methacrylamide
  • Polymers
  • hydroxyethyl methacrylate
  • Ibuprofen